Table 1 Baseline patient demographics
Variable | Pre GFR consult | Post GFR consult | P-value | ||
|---|---|---|---|---|---|
(N=232) | (N=239) | ||||
Age | 57.3 | 15.8 | 60.5 | 15.4 | 0.0532 |
Referral site | Â | Â | Â | Â | 0.0523 |
 HSC | 99 | 42.7% | 139 | 58.2% |  |
 SBGH | 49 | 21.1% | 57 | 23.9% | |
 SOGH | 55 | 23.7% | 43 | 18.0% | |
 Not specified | 29 | 12.5% | 0 | 0.0% | |
Gender | Â | Â | Â | Â | 0.6742 |
 Male | 127 | 54.7% | 136 | 56.9% |  |
 Female | 104 | 44.8% | 103 | 43.1% | |
 Not specified | 1 | 0.4% | 0 | 0.0% | |
Diabetes | Â | Â | Â | Â | 0.973 |
 No | 125 | 53.8% | 122 | 51.1% |  |
 Type I | 8 | 3.5% | 8 | 3.4% | |
 Type II | 97 | 41.8% | 99 | 41.4% | |
 Not Specified | 2 | 0.9% | 10 | 4.2% | |
Hypertension | Â | Â | Â | Â | 0.1062 |
 No | 83 | 35.8% | 68 | 28.5% |  |
 Yes | 147 | 63.4% | 166 | 69.5% | |
 Not specified | 2 | 0.9% | 5 | 2.1% | |
ACE/ARB inhibitors | Â | Â | Â | Â | 0.0011 |
 No | 134 | 57.8% | 91 | 38.1% |  |
 ACE only | 56 | 24.1% | 75 | 31.4% | |
 ARB only | 34 | 14.7% | 52 | 21.8% | |
 Both | 7 | 3.0% | 12 | 5.0% | |
 Not specified | 1 | 0.4% | 9 | 3.8% | |